Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
C
Chul‐Min Ahn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
553
Papers
10.5K
Citations
40
h-index
170
i10-index
Chul‐Min Ahn is an academic researcher from Yonsei University. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Acute Myocardial Infarction Research & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 40, co-authored 471 publications.
ORCID: 0000-0002-7071-4370Papers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
2020 · JAMA · 524 citations
https://doi.org/10.1001/jama.2020.7580
1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation
2021 · JACC: Cardiovascular Interventions · 89 citations
https://doi.org/10.1016/j.jcin.2021.06.003
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis
2023 · Journal of the American College of Cardiology · 48 citations
https://doi.org/10.1016/j.jacc.2023.02.007
Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial
2024 · European Heart Journal · 40 citations
https://doi.org/10.1093/eurheartj/ehae372
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat